Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May;41(5):691-711.
doi: 10.1007/s10096-022-04435-2. Epub 2022 Mar 30.

The interplay between anticancer challenges and the microbial communities from the gut

Claire Amaris Hobson  1 , Stéphane Bonacorsi  1   2 , André Baruchel  3 , Olivier Tenaillon #  1 , André Birgy #  4   5
Affiliations
Review

The interplay between anticancer challenges and the microbial communities from the gut

Claire Amaris Hobson et al. Eur J Clin Microbiol Infect Dis. 2022 May.

Abstract

Cancer being an increasing burden on human health, the use of anticancer drugs has risen over the last decades. The physiological effects of these drugs are not only perceived by the host's cells but also by the microbial cells it harbors as commensals, notably the gut microbiota. Since the early '50 s, the cytotoxicity of anticancer chemotherapy was evaluated on bacteria revealing some antimicrobial activities that result in an established perturbation of the gut microbiota. This perturbation can affect the host's health through dysbiosis, which can lead to multiple complications, but has also been shown to have a direct effect on the treatment efficiency.We, therefore, conducted a review of literature focusing on this triangular relationship involving the microbial communities from the gut, the host's disease, and the anticancer treatment. We focused specifically on the antimicrobial effects of anticancer chemotherapy, their impact on mutagenesis in bacteria, and the perspectives of using bacteria-based tools to help in the diagnostic and treatment of cancer.

Keywords: Anticancer drugs; Gut microbiota; Microbiology; Mutagenesis; Oncology.

PubMed Disclaimer

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
    1. Melichar B, Dvorák J, Hyspler R, Zadák Z (2005) Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents. Chemotherapy 51:336–338. https://doi.org/10.1159/000088957 - DOI - PubMed
    1. Pusztaszeri MP, Genta RM, Cryer BL (2007) Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations. Nat Clin Pract Gastroenterol Hepatol 4:442–453. https://doi.org/10.1038/ncpgasthep0896 - DOI - PubMed
    1. Montassier E, Al-Ghalith GA, Ward T, Corvec S, Gastinne T, Potel G et al (2016) Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection. Genome Med 28(8):49. https://doi.org/10.1186/s13073-016-0301-4 - DOI
    1. Samet A, Śledzińska A, Krawczyk B, Hellmann A, Nowicki S, Kur J et al (2013) Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream. Eur J Clin Microbiol Infect Dis 32:1393–400. https://doi.org/10.1007/s10096-013-1886-9 - DOI - PubMed - PMC

Substances

LinkOut - more resources